In another assay, the administration of BH-3120 and BH-2917b to mouse (CT-26)-xenografted hPD-1/hPD-L1/hCD137 triadic mice resulted in a TGI value of 79.6%, thereby treating cancer [163]. Here, PDCD1 is linked to cancer.